Clinical Trial Update: Single-Armed Use of ViviGen Cellular Bone Matrix in Patients Undergoing Posterolateral Lumbar Surgery [NA]

View source ↗

Summary

A terminated single-arm clinical trial evaluating ViviGen Cellular Bone Matrix in posterior lumbar fusion; results posted in 2024, with conditions including deg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Spinal Stenosis
• Spondylolisthesis
• Spondylosis

Drugs mentioned

• ViviGen Cellular Bone Matrix (cellular bone matrix)

Snippet

Sponsor: Ohio State University | Conditions: Degenerative Disc Disease, Spinal Stenosis | NA | Status: TERMINATED | Results posted: 2024-01-24